Company Filing History:
Years Active: 2019-2022
Title: Meifeng Jiang: Innovator in Pharmaceutical Research
Introduction
Meifeng Jiang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target cancer-related mechanisms. With a total of 4 patents to his name, Jiang's work is paving the way for innovative treatments.
Latest Patents
One of Jiang's latest patents is focused on a histone methyltransferase EZH2 inhibitor, which includes a preparation method and its pharmaceutical use. This invention relates to a compound represented by a specific general formula, aimed at treating diseases associated with the histone methyltransferase EZH2, especially cancer. Another notable patent involves a quinoline compound, which also includes a preparation method and medical use. This invention presents a novel quinolone compound that serves as an inhibitor for multiple protein kinases, with applications in the prevention and treatment of cancer.
Career Highlights
Meifeng Jiang is currently employed at Ancureall Pharmaceutical (Shanghai) Co., Ltd. His work at this company has allowed him to focus on innovative pharmaceutical solutions that address critical health challenges. Jiang's expertise in medicinal chemistry and drug development has positioned him as a key player in the industry.
Collaborations
Jiang collaborates with talented professionals in his field, including Jutong Si and Guan Zhong Wang. These collaborations enhance the research and development efforts at Ancureall Pharmaceutical, fostering an environment of innovation and discovery.
Conclusion
Meifeng Jiang's contributions to pharmaceutical research and his innovative patents highlight his commitment to advancing cancer treatment. His work continues to inspire future developments in the field, making a significant impact on healthcare.